Onco PGx and Remission Care: Genetic Testing for Personalized Post-Chemo Plans
Cancer remission marks a critical transition from active treatment to survivorship, yet optimizing long-term outcomes requires precision beyond conventional protocols. Oncology pharmacogenomics (Onco PGx) leverages genetic insights to tailor post-chemotherapy care, addressing interindividual variability in drug metabolism, toxicity risks, and residual disease management. This approach minimizes adverse effects, enhances therapeutic efficacy, and reduces relapse risks […]
Onco PGx and Remission Care: Genetic Testing for Personalized Post-Chemo Plans Read More »